Zevra Therapeutics
ZVRA
ZVRA
30 hedge funds and large institutions have $23.4M invested in Zevra Therapeutics in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 14 reducing their positions, and 3 closing their positions.
Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.75%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
1
Increased
4
Reduced
14
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
DM
1
Deerfield Management
New York
|
$2.82M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$997K |
| 3 |
3
Alyeska Investment Group
Chicago,
Illinois
|
$3.9M |
| 4 |
4
Millennium Management
New York
|
$0 |
| 5 |
5
BlackRock
New York
|
$307K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AG
26
Advisor Group
Phoenix,
Arizona
| $4K | 1,000 | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $3K | 835 | -753 | -47% |
|
28
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $2K | 423 | -30 | -7% |
|
29
Barclays
London,
United Kingdom
| $1K | 401 | +300 | +297% |
|
|
30
Millennium Management
New York
| – | – | -14,978 | Closed |
|
31
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -1,534 | Closed |
|
32
JPMorgan Chase & Co
New York
| – | – | -500 | Closed |
|
33
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 100 | – | – |
|